Cantor Fitzgerald
Cantor Fitzgerald is a leading brokerage service for Wall Street's fixed income inter-dealer community. Cantor is a recognized leader in the specialized areas of equity and fixed income capital markets, offering an impressive array of products and services to more than 5000 institutional clients around the world.
Cantor suffered a devastating loss on September 11, 2001, when the World Trade Center terrorist attacks claimed the lives of 658 of the company's 960 New York-based employees.
Howard W. Lutnick is the company's Chairman and CEO.
View Older Stories View More Recent Stories
-
Centene (CNC) PT Raised to $90 at Cantor Fitzgerald, "Growth Strategy Remains in Place"
-
Pre-Open Movers 06/16: (CLSN) (HOS) (FNSR) Higher; Whole Foods/Amazon News Impacts All Grocers (more...)
-
Valeant Pharma (VRX) Set to Open Positive Following 'Overweight' Rating
-
After-Hours Stock Movers 06/15: (HOS) (FNSR) (HZNP) Higher; (BAH) Lower (more...)
-
UPDATE: Cantor Fitzgerald Starts Shire (SHPG) at Overweight
-
UPDATE: Cantor Fitzgerald Starts Zoetis Inc. (ZTS) at Overweight, Sees Upside To EPS Estimates From M&A Among Other Things
-
UPDATE: Cantor Fitzgerald Starts Valeant Pharmaceuticals (VRX) at Overweight
-
UPDATE: Cantor Fitzgerald Starts Teva Pharma (TEVA) at Neutral, "We like Teva’s stock"
-
UPDATE: Cantor Fitzgerald Starts Theravance Biopharma (TBPH) at Overweight
-
UPDATE: Cantor Fitzgerald Starts Mylan (MYL) at Neutral
-
UPDATE: Cantor Fitzgerald Starts Mallinckrodt plc (MNK) at Overweight
-
UPDATE: Cantor Fitzgerald Starts Impax Laboratories (IPXL) at Overweight, Sees EPS Upside From Stratgeic M&A Deals
-
UPDATE: Cantor Fitzgerald Starts Horizon Pharma (HZNP) at Overweight
-
UPDATE: Cantor Fitzgerald Starts Endo International plc (ENDP) at Neutral
-
UPDATE: Cantor Fitzgerald Starts Allergen (AGN) at Neutral
-
UPDATE: Cantor Fitzgerald Starts Aclaris Therapeutis (ACRS) at Overweight
-
Cantor Fitzgerald Starts Perrigo Co. (PRGO) at Overweight
-
Nomura bond trader fraud trial ends in split U.S. jury verdict
-
Nicox to present at the 2017 BIO International Convention
-
Pre-Open Movers 06/15: (HTGM) (CTIC) (YTRA) Higher; (KR) (ARNA) (GOOGL) Lower (more...)
-
Pacific Bio (PACB) Prices 15.42M Share Offering at $3.10/Sh
-
Pacific Biosciences of California, Inc. Announces Pricing of Public Offering of Common Stock
-
UPDATE: Cantor Fitzgerald Starts Arena Pharma (ARNA) at Overweight; Not Your Father's ARNA
-
After-Hours Stock Movers 06/14: (APPS) (ROX) (LAKE) Higher; (PACB) (LNTH) (OAKS) Lower (more...)
-
Lantheus Holdings (LNTH) Announces 3M Share Secondary Offering of Common Stock
-
Lantheus Holdings, Inc. Announces Public Secondary Offering by Selling Stockholders of 3,000,000 Shares of Common Stock
-
Pacific Bio (PACB) to Offer Common Stock
-
Pacific Biosciences of California, Inc. Announces Proposed Public Offering of Common Stock
-
Data Dimensions Sponsors 17th Annual Shared Services for Finance & Accounting Conference
-
Cantor Fitzgerald Expands Healthcare Equity Research Team with Addition of Senior Specialty Pharma Analyst Louise Chen and Medical Technology Analyst Travis Steed
-
Acxiom (ACXM): SOTP Shows Significant Opportunity - Cantor Fitzgerald
-
Orchid Island Capital Announces June 2017 Monthly Dividend and May 31, 2017 RMBS Portfolio Characteristics
-
Cantor Fitzgerald Starts HMS Holdings (HMSY) at Overweight
-
Cantor Fitzgerald Maintains Neutral & $15 PT on Omeros (OMER) Following 'Breakthrough Therapy Designation Provides Validation for OMS721 in IgA Nephropathy'
-
Omnicell (OMCL) PT Raised to $47 at Cantor Fitzgerald; 'SOPS Contract & New Relationship with CompleteRX are Nice Positives'
-
Cantor Fitzgerald Downgrades athenahealth (ATHN) to Neutral on Valuation; Sees Low Probability of Outright Sale
-
Healthcare Realty Trust (HR) PT Raised to $38 at Cantor Fitzgerald Following Meetings with Management at NAREIT
-
Tivity Health (TVTY) PT Raised to $42 at Cantor Fitzgerald; Could Be Worth $46 in Take-Private Deal
-
Nicox: Issuing and admission to trading on the Euronext regulated market in Paris of 597,897 new shares awarded to existing Aciex shareholders following the US FDA's approval of ZERVIATE
-
Pre-Open Movers 06/08: (JWN) (BABA) (VSTM) Higher; (NLNK) (GEF) (MZOR) Lower (more...)
-
Synergy Pharma (SGYP): Trulance IBS-C sNDA Accepted - Cantor
-
After-Hours Stock Movers 06/07: (VSTM) (OKTA) (MESO) Higher; (GEF) (MSL) Lower (more...)
-
Cantor Fitzgerald Starts Mesoblast Limited (MESO) at Overweight; 'Underappreciated Late-Stage Cell Therapies'
-
HealthEquity, Inc (HQY) PT Raised to $55 at Cantor Fitzgerald
-
Netflix (NFLX) PT Raised to $190 at Cantor Fitzgerald
-
Cerner (CERN) PT Raised to $77 at Cantor Fitzgerald
-
Aldeyra Therapeutics (ALDX) Enters $20M ATM Offering Agreement
-
Wall Street sees Fed on track for rate hike in June despite tepid May jobs data: Reuters poll
-
Pre-Open Movers 06/02: (LULU) (SGYP) (AVGO) Higher; (RH) (BOOT) (SVRA) Lower (more...)
-
Freddie Mac Prices $1.1 Billion Multifamily K-Deal, KF31


